Standard BioTools
LAB
LAB
113 hedge funds and large institutions have $354M invested in Standard BioTools in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 52 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 138 → 113 (-25)
44% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 52
74% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 34
Holders
113
Holding in Top 10
2
Calls
$2.1M
Puts
$1.57M
Top Buyers
| 1 | +$14M | |
| 2 | +$11.3M | |
| 3 | +$5.22M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.37M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.06M |
Top Sellers
| 1 | -$4.44M | |
| 2 | -$3.68M | |
| 3 | -$3.35M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.05M |
| 5 |
Two Sigma Advisers
New York
|
-$2.99M |